Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570485
Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain TumorCenter Eugene MarquisNot Yet RecruitingNot Applicable
NCT07570485Not Yet Recruiting
Not Applicable
Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Br...Center Eugene Marquis
NCT07569965
Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCLMiltenyi Biomedicine GmbHNot Yet RecruitingPhase 2
NCT07569965Not Yet Recruiting
Phase 2
Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation i...Miltenyi Biomedicine GmbH
NCT07570836
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan HospitalNot Yet RecruitingPhase 1
NCT07570836Not Yet Recruiting
Phase 1
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung DiseaseShanghai Zhongshan Hospit...
NCT07569133
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's DiseaseHo-Won LeeEnrolling By InvitationNot Applicable
NCT07569133Enrolling By Invitation
Not Applicable
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressiv...Ho-Won Lee
NCT07568600
Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hyaluronate Carbomer Composite HydrogelThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07568600Not Yet Recruiting
Not Applicable
Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hy...The First Affiliated Hosp...
NCT07571213
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National Cohort of 315 042 ICU AdmissionsRegion DalarnaCompleted
NCT07571213Completed
—
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National...Region Dalarna
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07568808
Core Stabilization and Kinesthetic Training in Diplegic CPUniversity of LahoreCompletedNot Applicable
NCT07568808Completed
Not Applicable
Core Stabilization and Kinesthetic Training in Diplegic CPUniversity of Lahore
NCT07568730
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep 4 μM Ophthalmic Solution in Subjects With Neurotrophic KeratitisTearSolutions, Inc.RecruitingPhase 2
NCT07568730Recruiting
Phase 2
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study...TearSolutions, Inc.
NCT07569575
Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone FracturesHuaMg Perfection Med Tech (Suzhou) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07569575Not Yet Recruiting
Not Applicable
Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone FracturesHuaMg Perfection Med Tech...
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569783
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Nantong UniversityNot Yet RecruitingNot Applicable
NCT07569783Not Yet Recruiting
Not Applicable
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Na...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570810
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMShanghai Jiao Tong University School of MedicineNot Yet RecruitingNot Applicable
NCT07570810Not Yet Recruiting
Not Applicable
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD...Shanghai Jiao Tong Univer...
NCT07568769
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of FaisalabadCompletedNot Applicable
NCT07568769Completed
Not Applicable
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of Faisalabad
NCT07569848
Outcomes of Surgical Treatment Using a Custom-made Device for Total Ankle and Talar Replacement in the Management of Severe Cases of Bone Loss or Bone Compromise: a Pilot Study.Istituto Ortopedico RizzoliRecruiting
NCT07569848Recruiting
—
Outcomes of Surgical Treatment Using a Custom-made Device for Total Ankle and Ta...Istituto Ortopedico Rizzo...
NCT07570862
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisFate TherapeuticsNot Yet RecruitingPhase 2
NCT07570862Not Yet Recruiting
Phase 2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Neph...Fate Therapeutics
NCT07568847
Improving Hospital-To-Methadone Clinic Connection Using Implementation Support for Patients With Opioid Use DisorderNational Institute on Drug Abuse (NIDA)Not Yet RecruitingNot Applicable
NCT07568847Not Yet Recruiting
Not Applicable
Improving Hospital-To-Methadone Clinic Connection Using Implementation Support f...National Institute on Dru...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting4 (20%)
Completed3 (15%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Phase 25 (25%)
Not Specified3 (15%)
Phase 12 (10%)